ReviewResearch (Washington, D.C.)2026

Synergistic Potential of Immune Checkpoint Inhibitor Combined with Neutrophil-Targeted Therapy in Cancer Immunotherapy.

Huifang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.